Cargando…
SARS-CoV-2 mRNA Vaccine Elicits Sustained T Cell Responses Against the Omicron Variant in Adolescents
Vaccination against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has been acknowledged as an effective mean of preventing infection and hospitalization. However, the emergence of highly transmissible SARS-CoV-2 variants of concern (VOCs) has led to substantial increase in infections...
Autores principales: | Choi, Sujin, Kim, Sang-Hoon, Han, Mi Seon, Yoon, Yoonsun, Kim, Yun-Kyung, Cho, Hye-Kyung, Yun, Ki Wook, Song, Seung Ha, Ahn, Bin, Kim, Ye Kyung, Choi, Sung Hwan, Choe, Young June, Lim, Heeji, Choi, Eun Bee, Kim, Kwangwook, Hyeon, Seokhwan, Lim, Hye Jung, Kim, Byung-chul, Lee, Yoo-kyoung, Choi, Eun Hwa, Shin, Eui-Cheol, Lee, Hyunju |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
The Korean Association of Immunologists
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10475828/ https://www.ncbi.nlm.nih.gov/pubmed/37670807 http://dx.doi.org/10.4110/in.2023.23.e33 |
Ejemplares similares
-
Humoral Immune Response of Heterologous ChAdOx1 nCoV-19 and mRNA-1273 Prime-Boost Vaccination against SARS-CoV-2 Variants in Korea
por: Lim, Heeji, et al.
Publicado: (2023) -
Attitude and Acceptance of COVID-19 Vaccine in Parents and Adolescents: A Nationwide Survey
por: Lee, Hyunju, et al.
Publicado: (2022) -
Statement on healthcare system preparedness in response to COVID-19 Omicron subvariants BA.4 and BA.5 surge in Korea from the Korean Pediatric Society and Korean Society of Pediatric Infectious Diseases
por: Cho, Eun Young, et al.
Publicado: (2022) -
Long-term Effectiveness Associated With the BNT162b2 Vaccine Against SARS-CoV-2 Infection Among Adolescents in South Korea
por: Kim, Jia, et al.
Publicado: (2022) -
Neutralizing Activity Against SARS-CoV-2 Delta and Omicron Variants Following a Third BNT162b2 Booster Dose According to Three Homologous or Heterologous COVID-19 Vaccination Schedules
por: Choi, Ju-yeon, et al.
Publicado: (2022)